Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »Start With the Patient, Not the A1C: What Happens When Visits Ask “What Matters Most?”
Good Care, Bigger Bills: The Hidden Cost of High-Deductible Diabetes Plans
Learn why high-deductible health plans increase out-of-pocket costs for diabetes care and what these expenses mean for patients and providers.
Read More »Two Shots a Year for Hypertension? How RNA Silencing Could Transform Cardiometabolic Care
Poor medication persistence remains one of the hardest barriers to long-term blood pressure control. For people with diabetes, the stakes are especially high because hypertension adds to cardiovascular and kidney risk. Now, research into RNAi for hypertension in people with diabetes is raising an intriguing possibility: could an injection given …
Read More »The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome
Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …
Read More »New Diabetes Risk Factor Clinicians Are Paying Attention To: Loneliness
When most people think about diabetes risk factors, they picture blood sugar levels, diet, exercise habits, or genetics. However, researchers and clinicians are increasingly focusing on another factor that may have a profound impact on health outcomes: loneliness. The connection between loneliness and diabetes is gaining attention as evidence continues …
Read More »Diabetes Treatment Persistence: Why Patients Stop Therapy and What Clinicians Can Do
Why do so many patients begin treatment with good intentions, only to fall off track later? Staying consistent with diabetes treatment continues to challenge both patients and clinicians despite medical advances. While new therapies offer better control, long-term success still depends on consistency. However, many patients struggle to maintain routines, …
Read More »GLP-1 Adherence in the Real World: Why Patients Stop and How Clinicians Can Help
Staying consistent with GLP-1 therapy remains one of the biggest challenges in diabetes management today. While these therapies offer strong glycemic control, meaningful weight loss, and even cardiovascular benefits, many patients stop treatment earlier than expected. Why does that happen, and what can clinicians do differently? In many ways, GLP-1 …
Read More »